C07D 513/02
In which the condensed system contains two hetero rings
Official title: in which the condensed system contains two hetero rings
C07D513/02 (In which the condensed system contains two hetero rings) appears on 4,610 US grants and 4,843 published applications in this corpus.
Search patents in C07D- Granted patents
- 4,610
- Published applications
- 4,843
- Assignees
- 1,674
- Inventors
- 14,815
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 33 | 0 |
| 1977 | 31 | 0 |
| 1978 | 42 | 0 |
| 1979 | 43 | 0 |
| 1980 | 32 | 0 |
| 1981 | 43 | 0 |
| 1982 | 44 | 0 |
| 1983 | 29 | 0 |
| 1984 | 41 | 0 |
| 1985 | 54 | 0 |
| 1986 | 45 | 0 |
| 1987 | 38 | 0 |
| 1988 | 58 | 0 |
| 1989 | 59 | 0 |
| 1990 | 55 | 0 |
| 1991 | 56 | 0 |
| 1992 | 54 | 0 |
| 1993 | 62 | 0 |
| 1994 | 50 | 0 |
| 1995 | 66 | 0 |
| 1996 | 77 | 0 |
| 1997 | 105 | 0 |
| 1998 | 84 | 0 |
| 1999 | 54 | 0 |
| 2000 | 45 | 0 |
| 2001 | 59 | 16 |
| 2002 | 67 | 66 |
| 2003 | 82 | 130 |
| 2004 | 61 | 158 |
| 2005 | 66 | 159 |
| 2006 | 75 | 164 |
| 2007 | 91 | 173 |
| 2008 | 83 | 147 |
| 2009 | 96 | 201 |
| 2010 | 151 | 225 |
| 2011 | 127 | 226 |
| 2012 | 177 | 200 |
| 2013 | 163 | 190 |
| 2014 | 196 | 249 |
| 2015 | 214 | 233 |
| 2016 | 174 | 204 |
| 2017 | 201 | 193 |
| 2018 | 165 | 215 |
| 2019 | 164 | 222 |
| 2020 | 164 | 240 |
| 2021 | 162 | 189 |
| 2022 | 113 | 193 |
| 2023 | 129 | 253 |
| 2024 | 128 | 257 |
| 2025 | 122 | 201 |
| 2026 | 80 | 139 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Orexin receptor agonists and uses thereof29 Sep 2026US 12,747,252 B2Jazz Pharmaceuticals Ireland Limited
- Rock inhibitor and preparation method therefor and use thereof15 Sep 2026US 12,735,414 B2Wuhan Ll Science and Technology Development Co., Ltd.
- Materials for organic electroluminescent devices15 Sep 2026US 12,735,436 B2Universal Display Corporation
- Inhibitor of apoptosis (IAP) protein antagonists8 Sep 2026US 12,729,208 B2Sanford Burnham Prebys Medical Discovery Institute
- Voltage sensitive thiazolothiazole dyes and associated synthetic methods8 Oct 2026US 2026/0308176 A1
- Thiazolopyridin-7(4h)-one wrn inhibitors8 Oct 2026US 2026/0308177 A1Nimbus Wadjet, Inc.
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- Cyclic vinyl sulfone wrn inhibitors1 Oct 2026US 2026/0297070 A1Nimbus Wadjet, Inc.
- Bicyclic compounds as cdk inhibitors1 Oct 2026US 2026/0297080 A1BeOne Medicines I GmbH
Most cited
By later US patents
- Precursor to nucleic acid probe282US 4,754,065 ACetus Corporation · 1988
- Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof270US 6,110,929 A3M Innovative Properties Company · 2000
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997
- Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents219US 5,552,422 AMerck Frosst Canada, Inc. · 1996
- Heterocyclic compounds useful as inhibitors of tyrosine kinases202US 6,506,769 B2Boehringer Ingelheim Pharmaceuticals, Inc. · 2003